Abstracts

Fresh Semen Harbors HIV-Enhancing Amyloids and Decreases the Efficacy of Microbicides

Background: Semen, the most common vehicle for HIV transmission, enhances HIV infection in vitro. Previously, naturally-occurring peptides derived from the semen proteins prostatic acid phosphatase (PAP) and semenogelin (SEM) were shown to assemble into amyloid fibrils that markedly enhance HIV infection. Here, we investigated whether fresh semen samples contain these amyloids and affect the antiviral…

Semen’s HIV Enhancing Activity Is an Individual Characteristic Independent of VL

Background: Semen enhances HIV infection in vitro, and semen-derived amyloids made up of a peptide from the abundant protein semenogelin 1 (SEM1) are sufficient to mediate this activity. We sought to compare the infectivity-enhancing activity of semen among HIV infected men, and examine its relationship to concentrations of amyloidogenic peptides. Methods: We studied 188 paired…

Hyaluronan Reduces HIV Infection of CD4+ T Cells and Greatly Enhances HIV Inhibition by Tenofovir

Background: Better strategies are needed to prevent mucosal transmission of HIV. The major extracellular matrix receptorCD44, present on virion and target cells, has been reported to strongly influence viral infectivity. Topical formulations of antiviral drugs like tenofovir (TDF) are being studied in HIV prevention. We investigated how the natural ligand of CD44, hyaluronan, modulates HIV…

Alpha-defensins increase HIV transcytosis: role in STI-mediated enhanced HIV transmission

Background: Although mucosal epithelial cells provide the first-line of defense against HIV infection, HIV can cross the genital or intestinal epithelium by transcytosis. The risk of HIV transmission is increased in individuals with Sexually Transmitted Infections (STIs). Defensins are antimicrobial peptides important for mucosal innate immunity. Alpha-defensins, including human defensin 5 (HD5) and human neutrophil…

Optimization of vCCL2-Based CXCR4 Inhibitors by Phage Display and Rational Design

Background: The viral broad spectrum chemokine vCCL2/vMIP-II binds to CXCR4 and CXCR7 and protects host cells against HIV-1 infection. Peptide derived from vCCL2 N-terminus (vCCL21-21) displays modest CXCR4 binding affinity and antiviral properties compared to the parental chemokine but mutations within its CC motif have been shown to enhance its antiviral properties. In this study,…

HIV-1 Infection of Female Primary Genital Epithelial Cells After Pseudotyping With HTLV-1: Potential Driver of Sexual Transmission of HIV-1

Background: Young females are at high risk of HIV infection and constitute 75% of infected individuals in some sub-Saharan Africa countries. Some regions with high prevalence of HIV-1 are often also highly endemic for HTLV. HIV/HTLV co-infection in Africa, Latin America and the Caribbean basin is increasing and has emerged as a global health problem.…

Characterization of HIV-1 Envelopes in Acutely and Chronically Infected Injection Drug Users

Background: Mucosally acquired HIV-1 infection results from a limited number of variants, and these infecting strains potentially have unique properties, such as increased susceptibility to entry blockers, relative interferon-alpha (IFN-α) resistance, and replication differences in some primary cells. There is no data about the phenotypic properties of HIV-1 envelope variants found early after acquisition among…